NCT07400744 A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects Status NOT_YET_RECRUITING Phase PHASE1
NCT06895512 A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE3
NCT06296121 A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma Status RECRUITING Phase PHASE3
NCT05974969 A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05749276 Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM) Status NOT_YET_RECRUITING Phase PHASE1
NCT05306587 Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project. Status COMPLETED Phase N/A